Terumo Medical Corporation Executive and Leadership Team

Shana Stewart, the Chief Executive Officer, Medical Device Trading Region at Terumo Medical Corporation, manages the commercial distribution and market penetration of medical products. Overseeing regional sales strategies, the Chief Executive Officer, Medical Device Trading Region drives growth across diverse healthcare markets by aligning product availability with clinical demand. This leadership role involves coordinating with supply chain teams to ensure the seamless delivery of hollow-fiber technology and endovascular therapy solutions. By fostering strong relationships with hospital networks, Shana Stewart directly impacts the adoption rates of new medical devices. Stewart optimizes regional trade operations to maximize market share while maintaining strict adherence to regulatory requirements. Through the implementation of targeted commercial initiatives, the Chief Executive Officer, Medical Device Trading Region strengthens the presence of the company in competitive environments, ensuring that medical professionals receive the essential tools required for effective patient care and clinical excellence.

John Pinto, the Chief Financial Officer at Terumo Medical Corporation, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures rigorous compliance with international accounting standards while managing the budgetary requirements for manufacturing operations. This leadership role involves analyzing market trends to optimize resource distribution across the North American and global supply chains. By maintaining robust internal controls, John Pinto directly impacts the long-term economic stability of the company. Pinto secures the necessary funding for research and development initiatives, allowing the firm to maintain a competitive edge in the medical device sector. Through precise financial forecasting, the Chief Financial Officer supports the expansion of blood-management systems and clinical thermometer production, ensuring that fiscal objectives align with the broader mission of delivering high-quality medical technology to healthcare providers worldwide.

Keiichi Amatatsu, the President at Terumo Medical Corporation, directs the overarching corporate strategy and operational excellence of the organization. Overseeing the alignment of manufacturing goals with global market needs, the President ensures that the development of hollow-fiber technology remains at the forefront of medical innovation. This leadership role involves guiding the executive team to achieve sustainable growth while maintaining the high quality standards associated with the brand. By fostering a culture of continuous improvement, Keiichi Amatatsu directly impacts the operational efficiency of the company. Amatatsu coordinates with international stakeholders to expand the reach of endovascular therapy solutions into new territories. Through the execution of long-term business plans, the President secures the company's position as a leader in the medical device industry, ensuring that all departments work cohesively to deliver superior products that meet the evolving requirements of the global healthcare community.

Kota Yamamura, the President at Terumo Medical Corporation, manages the internal organizational structure and the execution of manufacturing protocols. Overseeing the production lifecycle of clinical thermometers and blood-management systems, the President ensures that all manufacturing processes meet rigorous safety and quality benchmarks. This leadership role involves optimizing factory output and supply chain logistics to meet the demands of the medical sector. By streamlining production workflows, Kota Yamamura directly impacts the cost-effectiveness and reliability of the company's product portfolio. Yamamura collaborates with engineering teams to integrate new technologies into existing manufacturing lines, enhancing overall product performance. Through the management of daily operations, the President maintains the integrity of the supply chain, ensuring that healthcare facilities receive consistent and timely access to essential medical equipment, thereby supporting the company's mission to provide reliable solutions for patient care.

Kalyan Balsubramanian, the Chief Information Officer & Chief Information Officer, ) & Vice President, Information Technology at Terumo Medical Corporation, architects the digital infrastructure supporting global manufacturing and data management. Overseeing the integration of advanced information systems, the Chief Information Officer & Chief Information Officer, ) & Vice President, Information Technology ensures secure data flow across all clinical and operational platforms. This leadership role involves modernizing the technological framework to support the production of blood-management systems and clinical thermometers. By implementing scalable cloud solutions, Kalyan Balsubramanian directly impacts the efficiency of internal business processes. Balsubramanian manages cybersecurity protocols to protect sensitive medical data, ensuring compliance with international privacy standards. Through the strategic deployment of enterprise software, the Chief Information Officer & Chief Information Officer, ) & Vice President, Information Technology enables seamless collaboration between research teams and manufacturing facilities, ultimately driving digital transformation across the entire organization.

Michael Martinelli, the Senior VP, Medcal Affairs & Chief Medical Officer at Terumo Medical Corporation, leads the clinical evaluation and medical safety protocols for all product lines. Overseeing the interaction between medical research and product development, the Senior VP, Medcal Affairs & Chief Medical Officer ensures that endovascular therapy solutions and other devices meet the highest clinical standards. This leadership role involves engaging with medical professionals to gather insights that drive future product innovation. By validating the clinical efficacy of new technologies, Michael Martinelli directly impacts the safety and success of patient treatments. Martinelli manages the medical affairs team to provide expert guidance on the application of medical products in clinical settings. Through the rigorous assessment of clinical data, the Senior VP, Medcal Affairs & Chief Medical Officer ensures that the company remains committed to evidence-based practices, ultimately improving patient outcomes through superior medical device design and application.